Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with non-segmental vitiligo of qi stagnation and blood stasis type who meet the above diagnostic criteria and TCM syndrome differentiation criteria; 2)Aged 18–75 years, regardless of gender; 3)With good compliance and who have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1)Pregnant women and lactating women; 2)Patients with severe impairment of cardiac, hepatic, or renal function; 3)Patients with major diseases such as severe cardiovascular and cerebrovascular diseases, hematological diseases, severe hypertension, or severe diabetes mellitus; 4)Patients with scar constitution or allergic constitution; 5)Patients who have participated in other drug clinical trials within 1 month or are currently participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area of White Patches; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vitiligo area scoring index,VASI;Presence of refractile dendritic melanocytes and cobblestone-like arranged refractile granules in the basal cell layer of different regions of target lesions (normal skin around white patches, perifollicular area of white patches, pigment islands of white patches) under skin CT;TCM Syndrome Score;VIPs-12 Scale Score;Peripheral Blood Immune and Oxidative Stress Indicato; | — |
Countries
China
Contacts
Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine